Sun Pharmaceutical Industries saw the highest growth of 86% in patent filings and 159% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 86% and grants by 159%. GlobalData’s DataBook provides a comprehensive analysis of Sun Pharmaceutical Industries‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Sun Pharmaceutical Industries has been focused on protecting inventions in United States(US) with 11 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 29% filings and 32% grants. The Australia(AU), United States(US), European Patent Office(EPO), and Spain(ES) patent Office are among the top ten patent offices where Sun Pharmaceutical Industries is filings its patents. Among the top granted patent authorities, Sun Pharmaceutical Industries has 32% of its grants in United States(US), 18% in Australia(AU) and 18% in European Patent Office(EPO).

F. Hoffmann-La Roche and Johnson & Johnson could be the strongest competitors for Sun Pharmaceutical Industries

Patents related to agricultural biotechnology and genetically modified organism (GMO) lead Sun Pharmaceutical Industries's portfolio

Sun Pharmaceutical Industries has the highest number of patents in agricultural biotechnology followed by, genetically modified organism (GMO) and climate change. For agricultural biotechnology, nearly 50% of patents were filed and no patents were granted in Q1 2024.

Pain related patents lead Sun Pharmaceutical Industries portfolio followed by inflammation, and diabetes

Sun Pharmaceutical Industries has highest number of patents in pain followed by inflammation, diabetes, obesity, and medical device. For pain, nearly 6% of patents were filed and 6% of patents were granted in Q1 2024.

For comprehensive analysis of Sun Pharmaceutical Industries's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.